动物模型在评估具有抗人巨细胞病毒潜在活性的药物方面的价值。 - Suppr

Suppr

超能文献

Value of animal models to evaluate agents with potential activity against human cytomegalovirus.

作者信息

Kern E R

机构信息

Department of Pediatrics, University of Alabama, Birmingham.

出版信息

Transplant Proc. 1991 Jun;23(3 Suppl 3):152-5, discussion 155.

PMID:1648821

Abstract

摘要

相似文献

Value of animal models to evaluate agents with potential activity against human cytomegalovirus.

Transplant Proc. 1991 Jun;23(3 Suppl 3):152-5, discussion 155.

Efficacy of ganciclovir and cidofovir against human cytomegalovirus replication in SCID mice implanted with human retinal tissue.

Antiviral Res. 2004 Jul;63(1):61-4. doi: 10.1016/j.antiviral.2004.02.002.

Predictive efficacy of SCID-hu mouse models for treatment of human cytomegalovirus infections.

Antivir Chem Chemother. 2001;12 Suppl 1:149-56.

New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.

Verh K Acad Geneeskd Belg. 1994;56(6):561-92.

Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients.

Blood. 2001 Sep 1;98(5):1626; author reply 1628. doi: 10.1182/blood.v98.5.1626.

Phosphonomethylether compounds as antiviral agents.

Transplant Proc. 1991 Jun;23(3 Suppl 3):156-8.

Cidofovir. Review of current and potential clinical uses.

Adv Exp Med Biol. 1999;458:111-20.

Interpreting human cytomegalovirus antiviral drug susceptibility testing: the role of mixed virus populations.

J Infect Dis. 1998 Mar;177(3):823-4. doi: 10.1086/514224.

Susceptibility of porcine cytomegalovirus to antiviral drugs.

J Antimicrob Chemother. 2004 Jun;53(6):975-80. doi: 10.1093/jac/dkh231. Epub 2004 Apr 29.

Resistance to antivirals in human cytomegalovirus: mechanisms and clinical significance.

Microbiologia. 1997 Sep;13(3):343-52.

引用本文的文献

Current and emerging antivirals for the treatment of cytomegalovirus (CMV) retinitis: an update on recent patents.

Recent Pat Antiinfect Drug Discov. 2012 Apr;7(1):8-18. doi: 10.2174/157489112799829765.

The search for new therapies for human cytomegalovirus infections.

Virus Res. 2011 May;157(2):212-21. doi: 10.1016/j.virusres.2010.11.004. Epub 2010 Nov 21.

Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art.

Antiviral Res. 2009 May;82(2):A84-98. doi: 10.1016/j.antiviral.2009.01.005.

Oral activity of a methylenecyclopropane analog, cyclopropavir, in animal models for cytomegalovirus infections.

Antimicrob Agents Chemother. 2004 Dec;48(12):4745-53. doi: 10.1128/AAC.48.12.4745-4753.2004.

Oral treatment of murine cytomegalovirus infections with ether lipid esters of cidofovir.

Antimicrob Agents Chemother. 2004 Sep;48(9):3516-22. doi: 10.1128/AAC.48.9.3516-3522.2004.

Activities of benzimidazole D- and L-ribonucleosides in animal models of cytomegalovirus infections.

Antimicrob Agents Chemother. 2004 May;48(5):1749-55. doi: 10.1128/AAC.48.5.1749-1755.2004.

Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir.

Antimicrob Agents Chemother. 2002 Apr;46(4):991-5. doi: 10.1128/AAC.46.4.991-995.2002.

In vitro activities of methylenecyclopropane analogues of nucleosides and their phosphoralaninate prodrugs against cytomegalovirus and other herpesvirus infections.

Antimicrob Agents Chemother. 2000 Jun;44(6):1506-11. doi: 10.1128/AAC.44.6.1506-1511.2000.

Activity of the anti-HIV agent 9-(2-phosphonyl-methoxyethyl)-2,6-diaminopurine against cytomegalovirus in vitro and in vivo.

Eur J Clin Microbiol Infect Dis. 1993 Jun;12(6):437-46. doi: 10.1007/BF01967438.

Treatment of murine cytomegalovirus infections in severe combined immunodeficient mice with ganciclovir, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, interferon, and bropirimine.

Antimicrob Agents Chemother. 1992 Sep;36(9):1837-42. doi: 10.1128/AAC.36.9.1837.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验